SCHEMBL8614152

SCHEMBL8614152

CCC(C)(C)Oc1ccc2nc(-c3ccccc3C)cc(C(=O)NC(=N)N)c2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA9 Q16790 7/20 0.50
CA2 P00918 6/20 0.50
CA12 O43570 5/20 0.50
CA1 P00915 4/20 0.50
ALDH1A1 P00352 6/20 0.46
HPGD P15428 5/20 0.46
KDM4E B2RXH2 4/20 0.46
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
HTT P42858 4/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
MAPT P10636 3/20 0.45
GPR55 Q9Y2T6 1/20 0.45
TACR3 P29371 1/20 0.43
LMNA P02545 2/20 0.41
RAB9A P51151 1/20 0.41
CYP1A2 P05177 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
CYP3A4 P08684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8615492 0.87 CA2 (0.53) CA9CA2CA12CA1ALDH1A1
SCHEMBL8612612 0.86 ALDH1A1 (0.44) CA9CA2CA12CA1ALDH1A1
SCHEMBL8616670 0.86 CA9 (0.65) CA9CA2CA12CA1ALDH1A1
SCHEMBL8618109 0.85 CA2 (0.51) CA9CA2CA12CA1ALDH1A1
SCHEMBL8619081 0.84 CA2 (0.56) CA9CA2CA12CA1ALDH1A1
SCHEMBL8617279 0.84 CA2 (0.50) CA9CA2CA12CA1ALDH1A1
SCHEMBL8615835 0.82 CA2 (0.48) CA9CA2CA12CA1ALDH1A1
SCHEMBL8614043 0.81 KMT2A (0.50) ALDH1A1HPGDKDM4EMEN1KMT2A
SCHEMBL8618938 0.81 CA2 (0.49) CA9CA2CA12CA1ALDH1A1
SCHEMBL8619277 0.81 CA2 (0.47) CA9CA2CA12CA1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0726254-B1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS (JP) 1998-05-06 EP disclosed
US-5627193-A MEDICAL DIAGNOSIS, CARDIOVASCULAR DIAORDERS AND PROTECTION OF ORGANS FOR TRANSPLANTATION MITSUI TOATSU CHEMICALS, INC. (JP) 1997-05-06 US disclosed
EP-0726254-A1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS, Inc. (JP) 1996-08-14 EP disclosed